Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews von Lieberman, S., Chen-Shtoyerman, R., Levi, Z., Shkedi-Rafid, S., Zuckerman, S., Bernstein-Molho, R., Levi, G. Reznick, Shachar, S. S., Flugelman, A., Libman, V., Kedar, I., Naftaly-Nathan, S., Lagovsky, I., Peretz, T., Karminsky, N., Carmi, S., Levy-Lahad, E., Goldberg, Y.

Volltext

A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer von Kedar, I., Walsh, L., Levi, G. Reznick, Lieberman, S., Shtaya, A. Abu, Nathan, S. Naftaly, Lagovsky, I., Tomashov-Matar, R., Goldenberg, M., Basel-Salmon, L., Katz, L., Aleme, O., Peretz, T. Yablonski, Hubert, A., Rothstein, D., Castellvi-Bel, S., Walsh, T., King, M. C., Pritchard, C. C., Levi, Z., Half, E., Laish, I., Goldberg, Y.

Volltext

In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: Potential mediating mechanisms and sex differences von Shaashua, L, Sominsky, L, Levi, B, Sorski, L, Reznick, M, Page, G.G, Ben-Eliyahu, S

Volltext